InvestorsHub Logo
Followers 2
Posts 105
Boards Moderated 0
Alias Born 10/18/2019

Re: Jesspro post# 9200

Monday, 10/21/2019 12:28:22 PM

Monday, October 21, 2019 12:28:22 PM

Post# of 17447
Jesspro, this analysis was only done for Aurinia based on the CR rates that management showed in their AURA presentation. Sites were taken from CLinicaltrial.com site. it shows the countries and the sites in each country. Overall it shows 31 countries but management in their latest MD&A confirmed only 27 countries. My death risk analysis was based on the 31 countries mentioned in clinicaltrial.com site (conservative compared to 27). The countries where I considered there is a risk of patient death are : Colombia, Guatemala, Puerto Rico, South Africa, Vietnam. 3rd world countries where sites are in the capital were not considered since it is not a remote site. Based on the 5 countries mentioned above there are 9 patients at risk in each arm. I assumed 50% death in the low VCS dose hence 2.2% . I could add the analysis here for public commentary but I don't know how to attach an Excel file in this forum. cheers
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News